Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Blokhin's Russian Cancer Research Center

Clinical trials sponsored by Blokhin's Russian Cancer Research Center, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a common mental health drug prevent weight loss in cancer patients? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 4 Not yet finished but already full! 6 Completed 1

Immunotherapy shows promise against Hard-to-Treat colorectal cancer

Disease control Completed

This phase 2 study tested the immunotherapy drug prolgolimab in 30 people with a specific type of colorectal cancer (MSI/dMMR) that had not spread. Participants received the drug for 6 months before planned surgery. The main goal was to see if the cancer completely disappeared in…

Phase 2 • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC